Oral treatment with an ET(A)-receptor antagonist inhibits neointima formation induced by endothelial injury

Pharmaceutical and Pharmacological Letters

Volumn 6, Issue 2, 1996, Pages 90-92

  Munter, K ^a   Hergenroder, S ^a   Unger, L ^a   Kirchengast, M ^a  

^a Knoll AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; INTIMA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0029815675     PISSN: 09399488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)